Ipsen Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
57 result(s) found, displaying 11 to 20
-
Prescription medicine decision summaryRelfydess (relabotulinumtoxinA, purified Botulinum toxin type A) has been approved for the temporary improvement in the appearance of glabellar lines ("frown lines") and lateral canthal lines ("crows feet").
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 2.5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 1.5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 1 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 10 mg capsule blister pack.
-
Cancellation by sponsorRequested by Ipsen Pty Ltd
-
Cancellation by sponsorRequested by Ipsen Pty Ltd
-
-
Prescription medicine decision summarySohonos (palovarotene) is approved to reduce the formation of heterotopic ossification.